CHINA PHARMA HOLDINGS, INC. (CPHI)

Key Insights

• China Pharma Holdings, Inc. has entered into a technology transfer agreement to acquire the ownership of an invention patent for Prinsepia Utilis Esterol Sublingual Tablets and its preparation method.
• The company will issue 12.6 million restricted shares of common stock, valued at $0.55 per share, to pay the $6.93 million transfer price.
• The technology transfer agreement includes the Transferor providing relevant technical services such as product R&D, registration materials, and other support.